Blue Cross Blue Shield of Massachusetts
Health Insurance Provider
Based in MA
🤖
AI Overview
With $1.7M in lobbying spend across 29 quarterly filings, Blue Cross Blue Shield of Massachusetts is a significant lobbying presence.
$1.7M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $240K |
| 2020 | $180K |
| 2021 | $220K |
| 2022 | $230K |
| 2023 | $240K |
| 2024 | $180K |
| 2025 | $180K |
Lobbying Firms
RED+BLUE STRATEGIES
What They Lobby For
- H.R. 1625 - Consolidated Appropriations Act of 2018 - Issues related to combating the opioid crisis and health insurance marketplace stability. H.R. 1301/ P.L. 115-124 - Continuing Resolution of 2018 - Issues related to policies to combat the opioid crisis, Issues related to enhancing Medicare coverage for people with chronic conditions, working for the inclusion of policies focused on mental health and palliative care and the health insurance tax delay. S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage. HHS regulations focused on insurance market stabilization. Legislative efforts by Senators Alexander and Murray to support market stabilization. Issues related to curbing the abuse of opioids in the United States.
- H.R. 1625 - Consolidated Appropriations Act of 2018 - Issues related to combating the opioid crisis for Medicare beneficiaries and others. H.R. 1301/ P.L. 115-124 - Continuing Resolution of 2018 - Issues related to policies to combat the opioid crisis, Issues related to enhancing Medicare coverage for people with chronic conditions, working for the inclusion of policies focused on mental health and palliative care. S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage. Issues related to curbing the abuse of opioids in the United States as they relate to entitlement coverage.
- H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs. S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis in the Medicare and Medicaid programs. S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage.
- H.R. 6 - Support for Patients and Communities Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis. S. 3120 - Helping to End Addiction and Lessen Substance Use Disorders Act of 2018 - Issues related to developing and supporting innovative ways to help solve the nation's opioid crisis. S.1334/H.R.2797 - The Patient Choice and Quality Care Act of 2017 - Issues related to better integration of end of life and palliative care into health care coverage. HHS regulations focused on the private insurance market. Legislative efforts to support market stabilization.
- Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues. Issues related to surprise billing and strategies for giving patients more information and peace of mind. Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team. HHS proposed rules related the treatment of rebates in Medicare Part D.
- HHS proposed rules related the treatment of rebates in Medicare Part D.
- S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency. Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues. Issues related to surprise billing and strategies for giving patients more information and peace of mind. Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team. HHS proposed rules related the treatment of rebates in Medicare Part D.
- H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency. Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues. Issues related to surprise billing and strategies for giving patients more information and peace of mind. Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team. HHS proposed rules related the treatment of rebates in Medicare Part D.
- H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries. HHS proposed rules related the treatment of rebates in Medicare Part D.
- H.R. 1865 - Further Consolidated Appropriations Act, 2020 - Issues related to the Health Insurance Tax. H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for consumers. S. 1895 - THe Lowering Health Care Costs Act - Issues related to surprise billing and transparency. Issues related to the reform of 42 CFR Part 2 to ensure better care for people with substance use disorder (SUD). Issues related to policies designed to strengthen and stabilize the nation's insurance markets including reinsurance programs, navigator programs, health insurance tax delay and other related issues. Issues related to surprise billing and strategies for giving patients more information and peace of mind. Issues related to improving treatment options for people with SUD, including the introduction of recovery coaches as part of the health care team. HHS proposed rules related the treatment of rebates in Medicare Part D.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.